@Sandman7591 Long-term, this should set up a potential 3 way battle from big pharma for the company ($AZN $MRK $BMY )
but that won't happen until we have data.

Short-term - have to keep in mind the 3.17M warrants that release around May 20th (exerciseable at .46)